Champlain Investment Partners LLC raised its position in shares of Cooper Companies Inc (NYSE:COO) by 0.3% during the 1st quarter, HoldingsChannel reports. The fund owned 390,720 shares of the medical device company’s stock after purchasing an additional 1,210 shares during the period. Champlain Investment Partners LLC’s holdings in Cooper Companies were worth $115,720,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Andra AP fonden purchased a new stake in shares of Cooper Companies during the 1st quarter worth approximately $4,176,000. GWM Advisors LLC raised its holdings in shares of Cooper Companies by 19.3% during the 1st quarter. GWM Advisors LLC now owns 1,117 shares of the medical device company’s stock worth $331,000 after acquiring an additional 181 shares in the last quarter. Neuburgh Advisers LLC raised its holdings in shares of Cooper Companies by 44.0% during the 1st quarter. Neuburgh Advisers LLC now owns 4,114 shares of the medical device company’s stock worth $1,218,000 after acquiring an additional 1,258 shares in the last quarter. Archford Capital Strategies LLC raised its holdings in shares of Cooper Companies by 4.7% during the 1st quarter. Archford Capital Strategies LLC now owns 942 shares of the medical device company’s stock worth $279,000 after acquiring an additional 42 shares in the last quarter. Finally, Wealthfront Advisers LLC raised its holdings in shares of Cooper Companies by 31.2% during the 1st quarter. Wealthfront Advisers LLC now owns 1,536 shares of the medical device company’s stock worth $455,000 after acquiring an additional 365 shares in the last quarter. 95.98% of the stock is currently owned by institutional investors and hedge funds.

Several analysts have recently issued reports on COO shares. Wells Fargo & Co upped their price objective on Cooper Companies from $325.00 to $356.00 and gave the stock an “outperform” rating in a report on Monday. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $325.00 price objective on shares of Cooper Companies in a report on Wednesday, March 6th. Zacks Investment Research raised Cooper Companies from a “sell” rating to a “hold” rating and set a $301.00 target price on the stock in a research report on Wednesday, May 29th. Jefferies Financial Group boosted their target price on Cooper Companies to $330.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Finally, KeyCorp boosted their target price on Cooper Companies from $296.00 to $314.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $315.36.

NYSE COO opened at $324.09 on Wednesday. The company has a market cap of $15.93 billion, a PE ratio of 28.18, a P/E/G ratio of 2.45 and a beta of 0.78. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.68 and a current ratio of 1.21. Cooper Companies Inc has a fifty-two week low of $221.65 and a fifty-two week high of $325.88.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, May 30th. The medical device company reported $2.94 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.76 by $0.18. The firm had revenue of $654.30 million for the quarter, compared to the consensus estimate of $655.00 million. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.86 EPS. On average, equities analysts expect that Cooper Companies Inc will post 12.24 earnings per share for the current year.

In other Cooper Companies news, CFO Brian G. Andrews sold 1,648 shares of the company’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $293.28, for a total value of $483,325.44. Following the transaction, the chief financial officer now owns 1,101 shares of the company’s stock, valued at approximately $322,901.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Kalkstein sold 3,500 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $316.28, for a total value of $1,106,980.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 98,700 shares of company stock worth $29,246,558. Corporate insiders own 1.70% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.watchlistnews.com/champlain-investment-partners-llc-purchases-1210-shares-of-cooper-companies-inc-nysecoo/3039190.html.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

See Also: Dividend Achievers

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.